← back to search

Yiming Mu

Chinese PLA General Hospital · CN
Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Diabetes Management and Research, and Metabolism, Diabetes, and Cancer.
h-index
51
citations
12,325
works
620
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study.
2026cited by 1position: contributordoi
Associations of general and central obesity with risk of premature mortality among Chinese adults: A nationwide prospective cohort study.
2026cited by 1position: contributordoi
Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real-world study.
2026cited by 0position: contributordoi
Glycaemic Outcomes of a Novel Model-Predictive-Control-Based Hybrid Closed-Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial.
2026cited by 0position: contributordoi
Safety and efficacy of hybrid closed-loop insulin pump therapy in adolescents and adults with type 1 diabetes in China.
2026cited by 0position: contributordoi
Mesenchymal Stem Cells Polarize Macrophages to an Anti-Inflammatory Phenotype to Ameliorate Diabetic Nephropathy.
2026cited by 0position: contributordoi
Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross-Sectional Study in China.
2026cited by 0position: contributordoi
Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
Diabetes Obesity and Metabolism 2025cited by 20position: middledoi
Association of body roundness index with cardiovascular disease and all-cause mortality among Chinese adults.
2025cited by 11position: contributordoi
Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
Cardiovascular Diabetology 2025cited by 10position: middledoi
Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study
Diabetologia 2025cited by 6position: middledoi
Exogenous Mitochondrial Pretreatment Enhances the Therapeutic Effect of UC-MSCs on NAFLD in Type 2 Diabetic Mice by Mediating Mitochondrial Transfer.
2025cited by 5position: contributordoi
Elucidating the heterogeneity of prediabetes through subphenotyping with a two-dimensional tree structure
Cell Reports Medicine 2025cited by 5position: middledoi
Circulating short-chain and branched short-chain fatty acids and the risk of incident type 2 diabetes: findings from the 4C study
Life Metabolism 2025cited by 5position: middledoi
Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the <scp>STEP</scp> 7 randomized clinical trial
Diabetes Obesity and Metabolism 2025cited by 4position: lastdoi
Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3.
2025cited by 3position: contributordoi
Efficacy and safety of once-weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial.
2025cited by 3position: contributordoi
Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3
Diabetes Therapy 2025cited by 3position: lastdoi
Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study.
2025cited by 2position: contributordoi
Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli-D Study.
2025cited by 1position: contributordoi
Associations of area-level socioeconomic status and individual factors with mortality in China: a nationwide prospective cohort study.
2025cited by 1position: contributordoi
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study.
2025cited by 1position: contributordoi
Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management.
2025cited by 1position: contributordoi
Phenotyping obesity through a two-dimensional tree structure reveals cardiometabolic heterogeneity
Cell Reports Medicine 2025cited by 1position: middledoi
Associations of general and central obesity with risk of premature mortality among Chinese adults: A nationwide prospective cohort study
Diabetes Obesity and Metabolism 2025cited by 1position: middledoi
[Central diabetes insipidus: diagnostic and therapeutic advances].
PubMed 2025cited by 0position: middledoi
Long- and Short-Term Cost-Effectiveness of Once-Weekly Semaglutide versus Dulaglutide for the Treatment of Type 2 Diabetes in China: A Hypothetical Modeling Exercise.
2025cited by 0position: contributordoi
Association between weight-adjusted-waist index and incident carotid atherosclerosis in the general adult population in Chinese communities: Evidence from the REACTION cohort study.
2025cited by 0position: contributordoi
Long-term cardiometabolic outcomes of primary bilateral macronodular adrenal hyperplasia.
2025cited by 0position: contributordoi
Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross-Sectional Study.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 74 papers (2019–2026)Xuefeng Yu · Xi'an Jiaotong University11 papers (2019–2026)Lulu Chen · University of Central Florida11 papers (2019–2026)Gang Chen · Tsinghua University9 papers (2021–2026) · 9 papers (2021–2026) · 9 papers (2019–2026)Jie Wang · Soochow University9 papers (2019–2022)Jiajun Zhao · Shandong Provincial Hospital9 papers (2016–2026)Guang Ning · Chinese People's Liberation Army8 papers (2019–2024)Li Yan · Air Force Medical University7 papers (2020–2026)Weijun Gu · Chinese PLA General Hospital7 papers (2019–2026) · 7 papers (2019–2026)Jieli Lu · Shihezi University6 papers (2021–2025)Xulei Tang · Bond University6 papers (2016–2026)Tiange Wang · Shenyang Agricultural University6 papers (2019–2025)Tao Yang · Shenyang Jianzhu University6 papers (2019–2026) · 6 papers (2021–2026)Binqi Li · Wuhan University of Technology6 papers (2022–2024) · 6 papers (2021–2025)Zuojie Luo · Sun Yat-sen University6 papers (2022–2026)